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The role of echocardiography in the management of patients with 
congestive heart failure. “Tanzanian experience”
Abstract
EEM ARO, R KAUSHIK
Objectives: To evaluate the usefulness o f  echocardiography in  m anaging patients w ith  congestive heart 
failure (CHF) and identify risks o f  m ortality  and heart failure re-adm issions during follow  up.
Design: A descrip tive prospective hospital based  study.
Setting: M uhim bili N ational H ospital and H indul M andal H ospital in  D ar es Salaam , Tanzania.
Subjects: 360 patients (198m ale and 162 fem ale) adm itted  due to  congestive heart failure had 
echocardiography done.
Main Outcome Measures: Identifying and characterizing echocardiographic features specific for evaluating 
patients w ith congestive heart failure. The patients w ere follow ed up for a t leas one year.
Results: 122 patients had norm al left ventricu lar ejection fraction (LVEF) and 238 patients had reduced left 
ventricular fraction. Patients w ith  norm al LVEF tended to  be o lder and fem ale and w ere m ore likely to have a 
history  o f  hypertension w hereas patients w ith reduced LVEF had a longer h istory  o f  heart failure due to 
dilated cardiom yopathy or valvular heart disease. Seventy nine patients (21.9% ) died. Patients w ith 
depressed ejection fraction had  a h igher death rate during follow  up as com pared w ith preserved ejection 
fraction.
Conclusion: We had dem onstrated that echocardiography is a useful non-invasive tool for assessing patients 
w ith  CH F due to systolic or diastolic dysfunction.
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Introduction followup.
Congestive heart failure (CHF) is a major public health 
problem that is associated with markedly diminished 
survival.1,2 The reported proportion of CHF patients 
with normal left ventricular systolic function has 
ranged from 13% to 75% and the reported annual 
mortality rate has varied from 1.3% to 17.5%.3 This 
implies that abnormal left ventricular diastolic function 
is the mechanism responsible for producing congestive 
symptoms in these patients.3 The approach to treatment 
may differ depending on whether systolic or diastolic 
dysfunction is predominant. Because clinical findings 
fail to distinguish patients with systolic or diastolic 
d y s fu n c tio n / severa l in s titu tio n s  recom m end 
echocardiography in all patients with suspected 
congestive heart failure.5
Unfortunately, no data are available on use and 
outcome of patients studied with echocardiography, in 
the management o f congestive heart failure in our 
region. Therefore, we prospectively assessed the 
relative proportions of normal versus impaired left 
ventricular systolic function among persons with CHF 
in a hospital based study sample and assessed the risks 
of mortality and heart failure re-admissions during
Materials and Methods 
Patients Selection.
We screened consecutive patients admitted to 
Muhimbili National Hospital and Hindu Mandal 
Hospital between April 1999 and March 2004, who 
were above eight years o f age and admitted with a 
diagnosis of congestive heart failure. This study was 
approved by the ethical committees o f both hospitals. 
All patients, in whom m odified Framingham  
diagnostic criteria6 for congestive heart failure were 
met, were included in the study. Physicians' notes were 
examined for indication o f major and minor criteria for 
congestive heart failure. The major diagnostic criteria 
included: paroxysmal nocturnal dyspnea; orthopnea; 
abnorm al ju g u la r  venous d isten s io n ; ra les; 
cardiomegaly; pulmonary oedema in the presence of 
the third heart sound and central venous pressure of 
more than 16 cm of water. The minor criteria included: 
oedema; night cough; dyspnoea on exertion; 
hepatomegaly; pleural effusion; tachycardia and weigh 
loss o f 4.5kg or more in five days. Persons were 
assigned a diagnosis of congestive heart failure if two
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major criteria were present or alternatively, if  one 
m ajor and two m inor c riteria  were present 
concurrently. Patients excluded were those having 
congestive heart failure secondary to high output state 
ornon-cardiac disease.
Clinical Observation.
Patients were interviewed within three days of 
admission for demographic information and baseline 
functional status. The age at diagnosis, gender and 
specific clinical characteristics were recorded. The 
presence o f underlying cardiovascular disease such as 
hypertension, valvular heart disease o f coronary heart 
disease was noted. The subsequent medical therapy 
prescribed after the diagnosis was recorded.
After a thorough medical history and physical 
examination, 12 lead electrocardiogram, full blood 
picture and blood biochemistry test were done. Two 
dimensional echocardiography was performed on 
study participants at the entry o f the study and after one 
year.
Echocardiographic Methods.
At the index examinations, all participants routinely 
underwent M-mode, two dimensional and Doppler 
echocardiography. Echocardiograms were performed 
at Hindu M andal H ospital Echocardiographic 
laboratory according to the recommendations o f the 
American Society o f Echocardiography.7 For the 
purpose o f this study, congestive heart failure patients 
were divided into two groups: those with normal left 
ventricular systolic function (LVEF>0.50) and those 
with impaired left ventricular systolic function 
(LVEF<0.50). For convenience these two groups are 
referred to as “preserved EF” and “depressed EF) 
groups respectively.
Follow Up.
All study subjects were routinely followed for up to one 
year. The duration o f follow up was defined as, the 
interval from the date o f the index examination at 
which the echocardiogram was obtained, to the date of 
death or the date of last contact.
Statistical Methods.
Data was entered and analysed using the Statistical 
Package for Social Sciences (SPSS/PCT version 10) 
for the IBM/AT microcomputer. Demographic, clinical 
characteristics and medications were candidate 
covariates. These were compared between patients 
with preserved EF and depressed EF using the Pearson 
Chi-square test for categorical variables and the 
Wilcoxon rank-sum test for continuous variables. 
Association between selected outcomes and ordinal 
categories o f EF (< 25,26 to 36,37 to 49 and > 50) were 
tested using the Chi-square for trend. Multivariable 
modes wre generated adjusting for covariates with a p 
value <0.20. The covariates eligible for entry in the 
final model included age, gender, duration o f CHF,
history o f coronary artery disease, history o f stroke, 
cigarette smoking, diabetes mellitus, pulmonary 
disease, atrial fibrillation, valvular disease, systolic and 
diastolic blood pressure and left ventricu lar 
hypertrophy on the electrocardiogram. A p value of 
<0.050 was considered statistically significant.
Results
A total o f 390 subjects with congestive heart failure 
(CHF) were studied. O f the 390 subjects with CHF, 30 
subjects (7.7%; 13 men and 17 women) were excluded. 
Twelve subjects because they did not attend any follow 
up examination during the study period, and 18 
subjects because o f inadequate echocardiograms. 
Three hundred and sixty (92.3%, 198 men and 162 
women) congestive heart failure patients had adequate 
echocardiogram after the onset o f CHF and were 
eligible for the present investigation. The median 
duration o f CHF at the time o f echocardiographic 
assessment was 1.4 years (range 0.2 to 11 years) and 
was similar for men and women.
On physical examination, third and fourth heart sounds 
were more common in the “depressed EF” group. On 
chest radiography, interstitial pulmonary oedema and 
bilateral pleural effusions were more common in the 
“depressed EF” group, whereas cardiomegaly was 
present equally in the depressed EF groups. 
Electrocardiographic features were similar in the two 
groups (Table I).
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Table I: Baseline clinical characteristics o f  congestive heart failure patients.
C haracteris tics P reserved  
EF (n=122)
D epressed  
EF (n=238)
p va lue
•  Age (years) 72+5 60+8 0.01
•  Male gender 10(8.2%) 118(78.9%) 0.0001
C ard iac  H istory
•  Any previous hospitalization for FH 18(15.6%) 114(47.9%) 0.001
•  Years of heart failure 1.2+2.8 3.1+2.9 0.003
•  Hypertension 91 (74.5%) 130 (54.6%) 0.001
•  Arrhythmia 11 (9%) 74 (31%) 0.004
•  Angina pectoris 10 (8.2%) 26 (11.9%) 0.89
•  Myocardial infarcation 7 (5.7%) 21 (8.8%) 0.04
•  CABG 1 (1.0%) 19(7.9%) 0.01
•  Valvular heart disease 21 (17.2%) 105(44%) 0.001
N on C ard iac  H istory
•  Renal insufficiency 8 (6.6%) 31 (13%) 0.01
•  Respiratory disease 10(8.2%) 21 (8.8%) 0.75
•  D ia b e te s  m e llitu s 12(9.8%) 48 (20.2%) 0.01
•  CVA/Stroke 6 (4.9%) 12(5.0%) 0.75
P hysica l E xam ination
•  Elevated JVP 55 (45%) 138 (57.9%) 0.01
•  Third heart sound 11 (9%) 121 (50.8%) 0.001
•  Fourth heart sound 4 (3.3%) 71 (29.8%) 0.0001
C h es t R ad iography
•  Cardiomegaly 82 (67.2%) 212(89.1%) 0.01
•  Interstial pulm. oedema 33 (27%) 126 (52.9%) 0.001
•  Pleural effusion 31 (25.4%) 114 (47.9%) 0.001
E lectrocard iogram
•  AF and atrial flutter 24(19.7%) 62 (26.1%) 0.32
•  LBBB 10 (8.2%) 19 (7.9%) 0.78
•  LVH 54 (44.3%0 21 (8.8%) 0.05
•  Any Ml pattern 17(13.9%) 57 (23.9%) 0.05
Labora to ry  va lues
•  Creatinine >200pmol/l 17(13.9% 107 (44.9%) 0.001
M ed icatio ns  D ischarge
•  Diuretics 38 (31.1%) 221 (92.9%) 0.001
•  Digoxin 40 (32.8%) 195 (81.9%) 0.001
•  ACE inhibitors 26 (21.3%) 155 (65.0%) 0.001
•  Beta blockers 49 (40.2%) 81 (34.0%) 0.20
•  Nitrates 15(12.3%) 35 (14.7%) 0.09
•  Vasodilators 9 (7.4%) 28(11.8%) 0.14
•  Warfarin 7 (5.7%) 62 (26.0%) 0.001
•  Asprin 36 (29.3%) 80 (33.1%) 0.41
Data presented as the mean value _  SD or number (%) o f subjects.
ACEI  -  Angiotension converting enzyme inhibitor.
CABG - Coronary artery bypass graft.
CVA - Cerebrovascular accident.
AF - Atrial fibrillation.
EF - Ejection fraction.
HF - Heart failure.
LBBB - Left bundle branch block.
LVH - Left ventricular hypertrophy.
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One hundred and twenty two CHF cases (33.9%, 95% 
Cl 21% to 43%) had normal LVEF, whereas 238 CHF 
cases (66.1%, 95% Cl 52% to 74%) hand reduced 
LVEF. O f the 162 women with CHF in the study 
sample, only 50 (30.9%, 95% Cl 15% to 49%) had 
reduced LVEF. In contrast o f 198 men with CHF, 143 
(72.2%; 95% Cl 57% to 87%) had reduced LVEF.
The distribution o f values o f LVEF among CHF cases 
is depicted in Figure I. Patients with “preserved EF” 
tended to be older and female and were more likely to 
have a history o f hypertension, whereas patients with 
“depressed EF” were more likely to have a longer 
history of heart failure due to dilated cardiomyopathy 
or valvular heart disease. Among the CHF cases, 
multiple logistic regression analysis revealed an 
association of female gender with the presence o f a 
normal LVEF (odd ratio for reduced LVEF 25%; 95% 
Cl 11% to 73%).
Figure I: The distribution o f  left ventricular ejection 
fraction (LVEF) values among men and women with 
congestive heart failure is displayed in the figure. One 
hundred and forty  three o f  198 men (72.2%) had a 
reduced LVEF (< 50%) compared with only 50 o f  62 
women (30.9%).
death rate during follow up as compared with patients 
with preserved EF (28.6% to 9.0%, p=0.001).
Table II: Unadjusted outcomes at 12 months follow  up.
C lin ical O utcom es P reserved D epressed p value
(E F (n=122) (E F (n=238)
M ortality
•  Death during follow up 11 (9%) 68 (28.6%) 0.01
.  Death during index 
R eadm issions
4 (3.3%) 2(1.0% ) 0.61
•  Readmission (any) 35 (28%) 115(48.3%) 0.02
•  Readmission (HF) 26 (40%) 39 (60%) 0.13
Data are presented as the number (%) ofsubjects or mean value +SD.
The proposition of patients who died decreased with 
greater EF; EF< 25% (31% n=32); EF 26% to 36% 
(15% n=26); EF 37% to 47% (13% n=8); EF >50% 
(11% n=T3) (p=0.005 for trend). The cause o f death 
could be ascertained in 64 o f the 79 subjects who died 
on follow up. Fifty percent o f deaths among CHF 
patients with a normal LVEF and 74% of deaths among 
CHF patients with a reduced LVEF were attributed to 
cardiovascular events.
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Patients in the “preserved EF” group were less likely to 
be treated with angiotensin converting enzyme 
inhibitor, digoxin or anticoagulant drugs, but they were 
as likely to be treated with diuretic agents. Twelve 
patients underwent valve replacement within 12 
months after diagnosis o f CHF. It is noteworthy that 
over 52% o f normal systolic CHF cases were taking 
digoxin without a history o f atrial fibrillation.
A total o f 150 patients (41.7%) were re-admitted for 
any cause with 65 (43.3%) re-admitted for heart failure. 
After adjusting for age, gender, history o f heart failure, 
years o f heart failure, baseline creatinine and discharge 
medications (ACE inhibitors, diuretics, beta blockers 
and digoxin) “preserved EF” was not associated with 
an increased risk o f all-cause re-admission (HR 1.02; 
95% Cl 8% to 14%; p=0.85). A total o f 79 patients 
(21.9%) died. Patients with depressed EF had a higher
Discussion
Although the epidemiology o f CHF has been well 
characterized,1'2 the relative contributions o f impaired 
versus intact LV systolic function to the prevalence o f 
this disease in our region, where infectious cardiology 
is common, is unknown. Using echocardiography, we 
found that 33.9% of the CHF cases in our sample had 
normal LVEF. Our results confirmed prior findings 
from hospital-based series1’8'9 which highlighted the 
frequent presence o f normal left ventricular systolic 
function among CHF patients.
Women with CHF were more likely than men to have 
a normal LVEF. Among CHF cases, 69.12% of the 
women had a normal LVEF compared with 27.78% o f 
men. This finding is consistent with prior reports o f a 
female preponderance among patients with CHF and 
normal left ventricular systolic function.1011
The assessment o f systolic function provided by 
echocardiography is critical to the management of 
patients with heart failure. After echocardiography, 
patients were treated more frequently with the four 
major classes o f drugs known to improve symptoms 
diuretics, digoxin, ACE inhibitors and beta-adrenergic 
blockers and much more frequently with ACE 
inhibitors (65% vs 25%), the drug known to prolong 
life in CHF. ACE inhibitors are indicated in patients 
with an EF< 40%, regardless o f their symptoms.12'13 
Although the recently published digoxin trial did not 
demonstrate an effect on survival, digoxin therapy did 
decrease the subsequent hospitalization for congestive 
heart failure in patients with abnormal systolic function 
and symptoms o f heart failure.14
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Most authorities agree that digoxin probably is not 
indicated in patients with heart failure and normal 
systolic function in the presence o f normal sinus 
rhythm. Also echocardiography may guide therapy by 
iden tify ing  pa tien ts  w ith advanced  d iasto lic  
dysfunction who may experience complications if 
treated aggressively with vasodilator or diuretic 
agents.15
Patients with diastolic dysfunction generally have a 
better outcome than do patients with systolic 
dysfunction.16 This was true in our study where the 
mortality o f the patients with normal left ventricular 
systolic function was 9.0% compared to 19.5% for 
those with depressed left ventricular systolic function. 
Certainly the greater the degree o f systolic dysfunction, 
the poorer the outcome so that estimation o f ejection 
fraction is, o f course, a critical variable in prognosis.
Limitation
A lthough  we screened  consecu tive  hosp ita l 
admissions, we probably did not capture the full 
spectrum of heart failure patients, particularly those 
with less severe symptoms, which may impact the 
generalizability o f our findings. The Framingham 
criteria are specific but relatively insensitive to define 
congestive heart failure status especially early 
manifestations.17 The selection o f a partition value of 
50% for separating normal from reduced LVEF may be 
criticised. It is uncertain for instance if  an LVEF value 
of 45% is depressed enough to initiate the maladaptive 
changes associated with the syndrome CHF. We chose 
this partition value because it is the most frequently 
utilized cut off point in published reports for separating 
normal left ventricular systolic function from from 
systolic dysfunction.3
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